SEP
CL icon

Signature Equity Partners’s Colgate-Palmolive CL Stock Holding History

Signature Equity Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57K Sell
17
-82
-83% -$7.17K ﹤0.01% 1226
2026
Q1 		$8.46K Sell
99
-220
-69% -$19.6K ﹤0.01% 843
2025
Q4 		$25.2K Buy
+319
New +$25K 0.01% 573

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Signature Equity Partners's CL Position: Q2 2026 in Review

Signature Equity Partners reduced its Colgate-Palmolive (CL) stake by 83% in Q2 2026, selling an estimated $7.17K and leaving 17 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Signature Equity Partners first reported a position in CL in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.2K in Q4 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Signature Equity Partners held 17 shares of Colgate-Palmolive worth $1.57K as of Q2 2026.
  • Signature Equity Partners sold 82 Colgate-Palmolive shares in Q2 2026, an estimated $7.17K.
  • Colgate-Palmolive made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1226 holding.
  • Signature Equity Partners first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Colgate-Palmolive position peaked at $25.2K in Q4 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.